Sympathetic Nervous System Responses to Psychosocial Stressors

  • Paul J. Mills
  • Joel E. Dimsdale
Part of the Perspectives on Individual Differences book series (PIDF)


Sympathetic nervous system (SNS) activity was initially inferred by responses of end organs such as sweat glands or heart rate. As biochemical techniques developed, it became possible to monitor SNS activity as mirrored in the urine and later in plasma. Now a number of other options are available for such study, including direct recording from SNS nerve fibers and quantification of adrenergic receptors. Regardless of the site of measurement, there is a great deal of variance in all SNS measures because the SNS is so exquisitely responsive to virtually all stimuli. In order to perceive individual differences or differences between tasks, the investigator must control for these perturbations of SNS activity.


Adrenergic Receptor Mental Stress Psychosocial Stressor Plasma Norepinephrine Plasma Catecholamine 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Aarons, R. D., Nies, A. S., Gerber, J. G., & Molinoff, P. B. (1983). Decreased beta adrenergic receptor density on human lymphocytes after chronic treatment with agonists. Journal of Pharmacology and Experimental Therapeutics, 224, 1–6.PubMedGoogle Scholar
  2. Abrams, W. B., & Solomon, H. M. (1969). The human platelet as a pharmacologic model for the adrenergic neuron: The uptake and release of norepinephrine. Clinical Pharmacologic Therapy, 10, 702–709.Google Scholar
  3. Anderson, E. A., Wallin, B. G., & Mark, A. L. (1987). Dissociation of sympathetic nerve activity in arm and leg muscle during mental stress. Hypertension, 9(111), 114–119.Google Scholar
  4. Anderson, E. A., Sinkey, C. A., Lawton, W. J., & Mark, A. L. (1989). Elevated sympathetic nerve activity in borderline hypertensive humans. Hypertension, 14, 177–183.PubMedCrossRefGoogle Scholar
  5. Barnes, R. F., Rasking, M., Gumbrecht, G., & Halter, J. B. (1982). The effect of age on the plasma catecholamine responses to mental stress. Journal of Clinical Endocrinology Metabolism, 24, 64–69.CrossRefGoogle Scholar
  6. Bonelli, J. (1982). Stress, catecholamines and beta-blockade. Ada Medica Scandinavica, 660, 214–218.Google Scholar
  7. Brisse, B., Tetsch, P., Schwill, E., & Bender, F. (1983). Comparative study of stress reactions during oral surgery after pindolol and metoprolol. Journal of Pharmacology, 14(2), 21–29.Google Scholar
  8. Brodde, O. E., Beckeringh, J. J., & Michel, M. C. (1987). Human heart beta-adrenoceptors: A fair comparison with lymphocyte beta-receptors?. Trends in Biochemical Sciences, 8, 403–407.Google Scholar
  9. Clamage, D., Vander, A., & Mouw, D. (1977). Psychosocial stimuli and human plasma renin activity. Psychosomatic Medicine, 39, 393–401.PubMedGoogle Scholar
  10. Collins, A., Eneroth, P., & Landgren, B. M. (1985). Psychoneuroendocrine stress responses and mood as related to the menstrual cycle. Psychosomatic Medicine, 47(6), 512–527.PubMedGoogle Scholar
  11. Daprada, M., & Picotti, G. B. (1979). Content and subcellular localisation of catecholamines and 5-hydroxytryptamine in human and animal blood platelets: Monoamine distribution between platelets and plasma. British Journal of Pharmacology, 65, 653–662.CrossRefGoogle Scholar
  12. DeQuattro, V., Loo, R., & Foti, A. (1985). Sympathoadrenal responses to stress: The linking of Type A behavior pattern to ischemic heart disease. Clinical Experimental Hypertension, A7(4), 469–481.CrossRefGoogle Scholar
  13. Dimsdale, J. E. (1984). Generalizing from laboratory studies to field studies of human stress physiology. Psychosomatic Medicine, 46, 463–469.PubMedGoogle Scholar
  14. Dimsdale, J. E., & Moss, J. (1980). Plasma catecholamines in stress and exercise. Journal of the American Medical Association, 243, 340–342.PubMedCrossRefGoogle Scholar
  15. Dimsdale, J. E., Hartley, H., Ruskin, J., Greenblatt, D. J., & LaBrie, R. (1984). Effect of beta blockage on plasma catecholamine levels during psychological and exercise stress. American Journal of Cardiology, 54, 182–185.PubMedCrossRefGoogle Scholar
  16. Dimsdale, J. E., O’Connor, D., Ziegler, M., & Mills, P. (1989). Does chromogranin A respond to short-term mild physiologic challenge?. Neuropsychopharmacology, 2, 237–240.PubMedCrossRefGoogle Scholar
  17. Dimsdale, J. E., Ziegler, M., & Mills, P. J. (1990). Renin correlates with blood pressure reactivity to Stressors. Nmropsychopharmacology, 3, 231–242.Google Scholar
  18. Dimsdale, J. E., Ziegler, M., Mills, P. J., Delehanty, S. G., & Berry, C. (1990). Effects of salt, race, and hypertension on reactivity to Stressors. Hypertension, 16, 573–580.PubMedCrossRefGoogle Scholar
  19. Eliasson, K., Hjemdahl, P., & Kahan, T. (1983). Circulatory and sympatho-adrenal responses to stress in borderline and established hypertension. Journal of Hypertension, 1, 131–139.PubMedCrossRefGoogle Scholar
  20. Esler, M., & Nestel, P. (1973). Renin and sympathetic nervous system responsiveness to adrenergic stimuli in essential hypertension. American Journal of Cardiology, 32, 643–649.PubMedCrossRefGoogle Scholar
  21. Esler, M., Leonard, P., Jackman, G., Bobik, A., & Skews, H. (1980). Study of noradrenaline uptake and spillover to plasma in normal subjects and patients with essential hypertension. Progress Biochemical Pharmacology, 17, 75–83.Google Scholar
  22. Esler, M., Skews, H., Leonard, P., Jackman, G., Bobika, J. G., & Korner, P. (1981a). Age-dependence of noradrenaline kinetics in normal subjects. Clinical Science, 60, 217–219.PubMedGoogle Scholar
  23. Esler, M., Jackman, G., Bobik, A., Leonard, P., Kelleher, D., Skews, H., Jennings, G., & Korner, P. (1981b). Norepinephrine kinetics in essential hypertension. Defective neuronal uptake of norepinephrine in some patients. Hypertension, 3, 149–156.PubMedCrossRefGoogle Scholar
  24. Freedman, R. R., Embury, J., Migaly, P., Keegan, D., Pandey, G. N., Javid, J. I., & Davis, J. M. (1990). Stress-induced desensitization of alpha2-adrenergic receptors in human platelets Psychosomatic Medicine, 52, 624–630.PubMedGoogle Scholar
  25. Goldstein, D. S., Dionne, R., Sweet, J., Gracely, R., Brewer, B., Gregg, R., & Keiser, H. R. (1982). Circulatory, plasma catecholamine, cortisol, lipid, and psychological responses to a real-life stress (third molar extractions): Effects of diazepam, sedation and of inclusion of epinephrine with the local anesthetic. Psychosomatic Medicine, 44, 259–272.PubMedGoogle Scholar
  26. Goldstein, D. S., Levinson, P., & Keiser, H. R. (1983). Plasma and urinary catecholamines during the human ovulatory cycle. American Journal of Obstetrics and Gynecology, 146, 824–829.PubMedGoogle Scholar
  27. Goldstein, D. S., Eisenhofer, G., Sax, F. L., Keiser, H. R., & Kopin, I. J. (1987). Plasma norepinephrine pharmacokinetics during mental challenge. Psychosomatic Medicine, 49, 591–605.PubMedGoogle Scholar
  28. Goldstein, D. S. (1983). Plasma catecholamines and essential hypertension: An analytical review. Hypertension, 5, 86–99.PubMedCrossRefGoogle Scholar
  29. Graafsma, S. J., van Tits, L. J., Westerhof, B., van Valderen, R., Lenders, J. W. M., Rodrigues de Miranda, J. F., & Thien, T. (1987). Adrenoceptor density on human blood cells and plasma catecholamines after mental arithmetic in normotensive volunteers. Journal of Cardiovascular Pharmacology, 10(4), S107–S109.Google Scholar
  30. Graafsma, S. J., Lenders, J. W., Peters, J. H., van Tits, L. J., Pieters, G. F., Rodrigues de Miranda, J. F., & Thien, T. (1988). Role of adrenaline in the short-term upregulation of beta-adrenoceptors in essential hypertensive and adrenalectomized females. Journal of Hypertension, 6(4), 578–580.Google Scholar
  31. Graafsma, S. J., van Tits, L. J., van Heyst, P., Reyenga, J., Lenders, J. W. M., Rodrigues de Miranda, J. F., & Thien, T. (1989). Adrenoceptors on blood cells in patients with essential hypertension before and after mental stress. Journal of Hypertension, 7, 519–524.PubMedCrossRefGoogle Scholar
  32. Hagbarth, K. E., & Valbo, A. B. (1968). Pulse and respiratory grouping of sympathetic impulses in human muscle nerves. Acta Physiohgica Scandinavica, 74, 96–108.CrossRefGoogle Scholar
  33. Harbin, T. J. (1989). The relationship between the Type A behavior pattern and physiological responsivity: A quantitative review. Psychophysiology, 26, 110–118.PubMedCrossRefGoogle Scholar
  34. Heine, H., & Weiss, M. (1987). Life stress and hypertension. European Heart Journal, 8, 45–55.PubMedCrossRefGoogle Scholar
  35. Herrmann, J., Schonecke, O., Wagner, H., Rosenthal, J., & Schmidt, T. (1980). Different endocrinal and hemodynamic response patterns to various noxious stimuli. Psychotherapeutics and Psychosomatics, 33, 160–166.CrossRefGoogle Scholar
  36. Hjemdahl, P., & Eliasson, K. (1979). Sympatho-adrenal and cardiovascular response to mental stress and orthostatic provocation in latent hypertension. Clinical Science, 57, 189s–191s.PubMedGoogle Scholar
  37. Hjemdahl, P., Fagius, J., Freyschuss, U., Wallin, B., Daleskog, M., Bohlin, G., & Perski, A. (1989). Muscle sympathetic activity and norepinephrine release during mental challenge in humans. American Journal of Physiology, 257, E654–E664.PubMedGoogle Scholar
  38. Hoffman, J. W., Benson, H., Arns, P. A., Stainbrook, G. L., Landsberg, L., Young, J. B., & Gill, A. (1982). Reduced sympathetic nervous system responsivity associated with the relaxation response. Science, 215, 190–192.PubMedCrossRefGoogle Scholar
  39. Jacob, R. G., & Chesney, M. A. (1986). Psychological and behavioral methods to reduce cardiovascular reactivity. In K. A. Mathews, S. Weiss, T. Detre, T. Dembroski, B. Falker, S. Manuck, & R. Williams, Jr. (Eds.), Handbook of stress, reactivity, and cardiovascular disease (pp. 417–460). New York: Wiley-Interscience Publications.Google Scholar
  40. Khan, J. P., Perumal, A. S., Gully, R. J., Smith, T. M., Cooper, T. B., & Klein, D. F. (1987). Correlation of Type A behavior with adrenergic receptor density: Implications for coronary artery disease pathogenesis. Lancet 24 (October), 937–939.CrossRefGoogle Scholar
  41. Khan, M. M., Sanson, P., Silverman, E. D., Engleman, E. G., and Melmon, K. L. (1986). Betaadrenergic receptors on human suppressor, helper, and cytolytic lymphocytes. Biochemical Pharmacology, 35, 1137–1142.PubMedCrossRefGoogle Scholar
  42. Kjeldsen, S., Os, I., Beckmann, S., Westheim, A., Hjermann, L., Leren, P., & Eider, I. (1986). Decreased noradrenergic sympathetic tone during controlled long-term low sodium treatment of mild essential hypertension. Journal of Hypertension, 4(6), s200–s202.Google Scholar
  43. Lake, C. R., & Ziegler, M. G. (1985). Techniques for assaying the catecholamines in psychiatric patients. In C. R. Lake & M. G. Ziegler (Eds.), The catecholamines in psychiatric and neurologic disorders (pp. 1–34). Woburn: Butterworth Publishers.Google Scholar
  44. Lake, C. R., Ziegler, M. G., & Kopin, I. J. (1976). Use of plasma norepinephrine for evaluation of sympathetic neuronal function in man. Life Sciences, 18, 1315–1326.PubMedCrossRefGoogle Scholar
  45. Landmann, R. M., Portenier, M., Staehelin, M., Wesp, M., & Box, R. (1988). Changes in betaadrenoceptors and leucocyte subpopulations after physical exercise in normal subjects. Naunym Schmiedebergs Archives Pharmacology, 337, 261–266.Google Scholar
  46. Lane, J. D., Adcock, A., Williams, R. B., & Kuhn, C. M. (1990). Caffeine effects on cardiovascular and neuroendocrine responses to acute psychosocial stress and their relationship to level of habitual caffeine consumption. Psychosomatic Medicine, 52, 320–336.PubMedGoogle Scholar
  47. Larsson, P. T., Martinsson, A., Olsson, G., & Hjemdahl, P. (1989). Altered adrenoceptor responsiveness during adrenaline infusion but not during mental stress: Differences between receptor subtypes and tissues. British Journal of Clinical Pharmacology, 28, 663–674.PubMedCrossRefGoogle Scholar
  48. Lehmann, J. W., Goodale, I. L., & Benson, H. (1986). Reduced pupillary sensitivity to topical phenylephrine associated with the relaxation response. Journal of Human Stress, Fall, 12, 101–104.Google Scholar
  49. Liggett, S. B., Marker, J. C., Shah, S. D., Roper, C. L., & Cryer, P. E. (1988). Direct relationship between monoleukocyte and lung beta-adrenergic receptors and apparent reciprocal regulation of extravascular, but not intravascular, alpha-and beta-adrenergic receptors by the sympathochromaffin system in humans. Journal of Clinical Investigation, 82, 48–56.PubMedCrossRefGoogle Scholar
  50. Lorimer, A. R., Macfarlane, P. W., Provan, G., Duffy, T., & Lawrie, T. D. (1971). Blood pressure and catecholaine responses to “stress” in normotensive and hypertensive subjects. Cardiovascular Research, 5, 169–173.PubMedCrossRefGoogle Scholar
  51. Lovallo, R., Pincomb, G. A., Sung, B. H., Passey, R. B., Sausen, K. P., & Wilson, M. F. (1989). Caffeine may potentiate adrenocortical stress responses in hypertensive-prone men. Hypertension, 14, 170–176.PubMedCrossRefGoogle Scholar
  52. Lowenstein, O., & Lowenfeld, I. (1969). The pupil. In H. Davson (Ed.), The eye, (Vol. III). New York: Academic Press.Google Scholar
  53. Lundberg, J. M., Martinsson, A., Hemsen, A., Theodorsson-Norheim, E., Svedenhag, J., Ekblom, B., & Hjemdahl, P. (1985). Co-release of neuropeptide Y and catecholamines during physical exercise in man. Biochemical Biophysical Research Communications, 133, 30–36.CrossRefGoogle Scholar
  54. Lundberg, J. M., Pernow, J., Franco-Cersceda, A., & Rudehill, A. (1987). Effects of antihypertensive drugs on sympathetic vascular control in relation to neuropeptide Y. Journal of Cardiovascular Pharmacology, 10(12), s51–s68.PubMedCrossRefGoogle Scholar
  55. Maisel, A. S., Harris, T., Reardon, C. A., & Michel, M. C. (in press). Beta-adrenergic receptors in lymphocyte subsets following exercise: Alterations in normal individual and patients with congestive heart failure. Circulation, 82, 2003-2010.Google Scholar
  56. Meyerhoff, J. L., Oleshansky, M. A., & Mougey, E. H. (1988). Stressful interview activates autonomic, second messenger, renin-angiotensin and pituitary systems. Psychosomatic Medicine, 50, 196–197.Google Scholar
  57. Michel, M. C., Otto-Erich, O., & Insel, P. A. (1990). Peripheral adrenergic receptors in hypertension. Hypertension, 16, 107–120.PubMedCrossRefGoogle Scholar
  58. Mills, P. J., & Dimsdale, J. E. (1988). The promise of receptor studies in psychophysiologic research. Psychosomatic Medicine, 50, 555–566.PubMedGoogle Scholar
  59. Mills, P. J., & Dimsdale, J. E. (1991). Cardiovascular reactivity to psychosocial Stressors: A review of the effects of beta-blockage. Psychosomatics, 32, 209–220.PubMedCrossRefGoogle Scholar
  60. Mills, P. J., Schneider, R. H., & Dimsdale, J. E. (1989). Anger assessment and reactivity to stress. Journal of Psychosomatic Research, 33(3), 379–382.PubMedCrossRefGoogle Scholar
  61. Mills, P. J., Schneider, R. H., Hill, D., Walton, K. G., & Wallace, R. K. (1990). Beta-adrenergic receptor sensitivity in subjects practicing Transcendental meditation. Journal of Psychosomatic Research, 34, 29–33.PubMedCrossRefGoogle Scholar
  62. Mills, P. J., Dimsdale, J. E., Ziegler, M., Berry, C., & Bain, B. (in press). Beta-adrenergic receptors predict heart rate reactivity to a psychosocial Stressor. Psychosomatic Medicine.Google Scholar
  63. Morganti, A., Sala, C., Turolo, L., Palermo, A., & Zanchetti, A. (1985). Participation of the reninangiotensin system in the maintenance of blood pressure during changes in posture in patients with essential hypertension. Journal of Hypertension, 3, 55–61.PubMedCrossRefGoogle Scholar
  64. Morrell, E. M., & Hollandsworth, J. G. (1986). Norepinephrine alterations under stress following the regular practice of meditation. Psychosomatic Medicine, 48, 270–277.PubMedGoogle Scholar
  65. Nami, R., Bianchini, C., Aversa, A. M., Gragnani, S., Papini, L., Peruzzi, C., Lucani, B., Perrone, A. F., Johnson, S., Gennari, C. (1986). Circulating levels of catecholamines and cyclic AMP during handgrip test in borderline hypertension. Journal of Cardiovascular Pharmacology, 8(2), s142–s144.PubMedCrossRefGoogle Scholar
  66. Niarchos, A. P., Pickering, T. G., Morganti, A., & Laragh, J. H. (1982). Plasma catecholamines and 2cardiovascular responses during converting enzyme inhibition in normotensive and hypertensive man. Clinical Experimental Hypertension, A4 (4&5), 761–789.CrossRefGoogle Scholar
  67. O’Connor, D., Frigon, R., & Sokoloff, R. (1984). Human chromogranin A: Purification and characterization from catecholamine storage vesicles of human pheochromocytoma. Hypertension, 6, 2–12.PubMedCrossRefGoogle Scholar
  68. Pacak, K., Nedvidkova, J., Horvath, M., Frantik, E., Husek, P., & Pacovsky, V. (1989). High cardiovascular reactivity to psychological challenge associated alternatively with high density of beta-adrenergic receptors or with high resting level of catecholamines. Activas Nervosa Superior, 31, 96–99.Google Scholar
  69. Palmer, C. J., Ziegler, M. G., & Lake, C. R. (1978). Response of norepinephrine and blood pressure to stress increases with age. Journal of Gerontology, 33, 482–487.PubMedCrossRefGoogle Scholar
  70. Pernow, J., Lundberg, J. M., Kaijser, L., Hjemdahl, P., Theodorsson-Norheim, E., Martinsson, A., & Pernow, B. (1986). Plasma neuropeptide Y-like immunoreactivity and catecholamines during various degrees of sympathetic activation in man. Clinical Physiology, 6, 561–578.PubMedCrossRefGoogle Scholar
  71. Pincomb, G. A., Lovallo, W. R., Passey, R. B., Bracket, D. J., & Wilson, M. F. (1987). Caffeine enhances the physiological response to occupational stress in medical students. Health Psychology, 62, 101–112.CrossRefGoogle Scholar
  72. Schneider, R. H., Julius, S., Moss, G., Dielman, T. E., Zweifler, A. J., & Karunas, R. (1987). New markers for Type A behavior: Pupil size and platelet epinephrine. Psychosomatic Medicine, 49, 579–590.PubMedGoogle Scholar
  73. Sever, P. S., Peart, W. S., Davies, I. B., Tunbridge, R. D., & Gordon, D. (1979). Ethnic differences in blood pressure with observations on noradrenaline and renin. Clinical Experimental Hypertension, 1(6), 745–760.CrossRefGoogle Scholar
  74. Smits, P., Reters, G., & Thien, T. (1986). The role of epinephrine in the circulatory effects of coffee. Clinical Pharmacology Therapeutics, 40, 431–437.CrossRefGoogle Scholar
  75. Sullivan, P., Procci, W., DeQuattro, V. Şchoentgen, S., Levine, D., van Der Meulen, J., & Bornheimer, J. (1981). Anger, anxiety, guilt, and increased basal and stress-induced neurogenic tone: Causes or effects in primary hypertension. Clinical Science, 61, 389s–392s.PubMedGoogle Scholar
  76. Tatemoto, K. (1982). Neuropeptide Y: Complete amino acid sequence of the brain peptide. Proceedings of the American Academy Science, 79, 5485–5489.CrossRefGoogle Scholar
  77. Tischenkel, N. J., Saab, P. G., Schneiderman, N., Nelesen, R. A., Pasin, R. D., Goldstein, D. A., Spitzer, S. B., Woo-Ming, R., & Weidler, D. J. (1989). Cardiovascular and neurohormonal responses to behavioral challenge as a function of race and gender. Health Psychology, 8(5), 503–524.PubMedCrossRefGoogle Scholar
  78. Trap-Jensen, J., Carlsen, J. E., Hartling, O. J., Svendsen, T. L., Tango, M., & Christensen, N. J. (1982). Beta-adrenoceptor blockade and psychic stress in man. A comparison of the acute effects of labetalol, metoprolol, pindolol, and propranolol on plasma levels of adrenaline and noradrenaline. British Journal of Clinical Pharmacology, 13, 391s–395s.PubMedCrossRefGoogle Scholar
  79. Ward, M. M., Mefford, I. N., Parker, S. D., Chesney, M. A., Taylor, C. B., Keegan, D. L., & Barchas, J. D. (1983). Epinephrine and norepinephrine responses in continually collected human plasma to a series of Stressors. Psychosomatic Medicine, 45, 471–486.PubMedGoogle Scholar
  80. Williams, R. B. (1987). Refining the Type A hypothesis: Emergence of the hostility complex. American Journal of Cardiology, 60, 27J–32J.PubMedCrossRefGoogle Scholar
  81. Yamada, Y., Miyajima, E., Tochikubo, O., Matsukawa, T., & Ishii, M. (1989). Age-related changes in muscle sympathetic nerve activity in essential hypertension. Hypertension, 13, 870–877.PubMedCrossRefGoogle Scholar
  82. Ziegier, M. G., Kennedy, B., & Elayan, H. (1989a). Extrarenal adrenaline formation by two separate enzymes. Experientia, 45, 718–720.CrossRefGoogle Scholar
  83. Ziegler, M. G., Kennedy, B., Elayan, H. (1989b). Rat renal epinephrine synthesis. Journal of Clinical Investigation, 84, 1130–1133.PubMedCrossRefGoogle Scholar
  84. Zweifler, A. J., & Julius, S. (1982). Increased platelet catecholamine content in pheochromocytoma: A diagnostic test in patients with elevated plasma catecholamines. New England Journal of Medicine, 306, 890–894.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1992

Authors and Affiliations

  • Paul J. Mills
    • 1
  • Joel E. Dimsdale
    • 1
  1. 1.Department of PsychiatryUniversity of California at San DiegoLa JollaUSA

Personalised recommendations